These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3478163)

  • 21. [Limb salvage and amputation in osteosarcoma: report of 31 cases].
    Zhang H; Luo X; Wang Z
    Zhonghua Wai Ke Za Zhi; 1997 Sep; 35(9):556-7. PubMed ID: 10678034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
    Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
    J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
    Bacci G; Ferrari S; Bertoni F; Ruggieri P; Picci P; Longhi A; Casadei R; Fabbri N; Forni C; Versari M; Campanacci M
    J Clin Oncol; 2000 Dec; 18(24):4016-27. PubMed ID: 11118462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of chemotherapy before limb-sparing surgery for osteosarcoma.
    Ishida T; Takami M
    Int Orthop; 1992; 16(1):59-61. PubMed ID: 1572773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup.
    Lewis IJ; Weeden S; Machin D; Stark D; Craft AW
    J Clin Oncol; 2000 Dec; 18(24):4028-37. PubMed ID: 11118463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
    Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
    J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.
    Navid F; Santana VM; Neel M; McCarville MB; Shulkin BL; Wu J; Billups CA; Mao S; Daryani VM; Stewart CF; Kunkel M; Smith W; Ward D; Pappo AS; Bahrami A; Loeb DM; Reikes Willert J; Rao BN; Daw NC
    Int J Cancer; 2017 Oct; 141(7):1469-1477. PubMed ID: 28631382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
    Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
    J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limb salvage procedures for children with osteosarcoma: an alternative to amputation.
    Rao BN; Champion JE; Pratt CB; Carnesale P; Dilawari R; Fleming I; Green A; Austin B; Wrenn E; Kumar M
    J Pediatr Surg; 1983 Dec; 18(6):901-8. PubMed ID: 6582250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
    Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M
    Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Casadei R; Brach Del Prever A; Tienghi A; Mancini A
    J Chemother; 1993 Aug; 5(4):237-46. PubMed ID: 8229152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience.
    Bacci G; Ruggieri P; Bertoni F; Ferrari S; Longhi A; Biagini R; Zavatta M; Versari M; Forni C
    Oncol Rep; 2000; 7(5):1129-33. PubMed ID: 10948351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
    Rosen G
    Cancer Treat Res; 1993; 62():49-54. PubMed ID: 8096759
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of chemotherapy combined with caffeine for osteosarcoma.
    Tsuchiya H; Yasutake H; Yokogawa A; Baba H; Ueda Y; Tomita K
    J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
    Chuman H; Fukuma H; Beppu Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
    Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
    Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.